Your browser doesn't support javascript.
loading
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Guo, Xiao-Jun; Lu, Jia-Cheng; Zeng, Hai-Ying; Zhou, Rong; Sun, Qi-Man; Yang, Guo-Huan; Pei, Yan-Zi; Meng, Xian-Long; Shen, Ying-Hao; Zhang, Peng-Fei; Cai, Jia-Bin; Huang, Pei-Xin; Ke, Ai-Wu; Shi, Ying-Hong; Zhou, Jian; Fan, Jia; Chen, Yi; Yang, Liu-Xiao; Shi, Guo-Ming; Huang, Xiao-Yong.
Afiliação
  • Guo XJ; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Lu JC; Liver Cancer Institute, Fudan University, Shanghai, China.
  • Zeng HY; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education of the People's Republic of China, Shanghai, China.
  • Zhou R; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Sun QM; Liver Cancer Institute, Fudan University, Shanghai, China.
  • Yang GH; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education of the People's Republic of China, Shanghai, China.
  • Pei YZ; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Meng XL; Department of Transfusion, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shen YH; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang PF; Liver Cancer Institute, Fudan University, Shanghai, China.
  • Cai JB; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education of the People's Republic of China, Shanghai, China.
  • Huang PX; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ke AW; Liver Cancer Institute, Fudan University, Shanghai, China.
  • Shi YH; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education of the People's Republic of China, Shanghai, China.
  • Zhou J; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Fan J; Liver Cancer Institute, Fudan University, Shanghai, China.
  • Chen Y; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education of the People's Republic of China, Shanghai, China.
  • Yang LX; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shi GM; Liver Cancer Institute, Fudan University, Shanghai, China.
  • Huang XY; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education of the People's Republic of China, Shanghai, China.
Front Immunol ; 12: 705378, 2021.
Article em En | MEDLINE | ID: mdl-34526987
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Linfócitos do Interstício Tumoral / Colangiocarcinoma / Antígeno B7-H1 / Antígeno CTLA-4 / Receptor de Morte Celular Programada 1 / Proteínas de Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Linfócitos do Interstício Tumoral / Colangiocarcinoma / Antígeno B7-H1 / Antígeno CTLA-4 / Receptor de Morte Celular Programada 1 / Proteínas de Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article